Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4.

Zhu J, Liao G, Shan L, Zhang J, Chen MR, Hayward GS, Hayward SD, Desai P, Zhu H.

J Virol. 2009 May;83(10):5219-31. doi: 10.1128/JVI.02378-08.

2.
3.

Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling.

Li R, Liao G, Nirujogi RS, Pinto SM, Shaw PG, Huang TC, Wan J, Qian J, Gowda H, Wu X, Lv DW, Zhang K, Manda SS, Pandey A, Hayward SD.

PLoS Pathog. 2015 Dec 29;11(12):e1005346. doi: 10.1371/journal.ppat.1005346.

4.

DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.

Wang'ondu R, Teal S, Park R, Heston L, Delecluse H, Miller G.

PLoS One. 2015 May 7;10(5):e0126088. doi: 10.1371/journal.pone.0126088.

5.

Replication licensing of the EBV oriP minichromosome.

Hirai K, Shirakata M.

Curr Top Microbiol Immunol. 2001;258:13-33. Review.

PMID:
11443858
6.

In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.

Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Tsurumi T.

J Biol Chem. 2004 Dec 24;279(52):54817-25.

7.

Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins.

Chang CW, Lee CP, Huang YH, Yang PW, Wang JT, Chen MR.

J Virol. 2012 Aug;86(15):8072-85. doi: 10.1128/JVI.01058-12.

8.

SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.

Li R, Wang L, Liao G, Guzzo CM, Matunis MJ, Zhu H, Hayward SD.

J Virol. 2012 May;86(10):5412-21. doi: 10.1128/JVI.00314-12.

9.

DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.

Yasuda A, Noguchi K, Minoshima M, Kashiwazaki G, Kanda T, Katayama K, Mitsuhashi J, Bando T, Sugiyama H, Sugimoto Y.

Cancer Sci. 2011 Dec;102(12):2221-30. doi: 10.1111/j.1349-7006.2011.02098.x.

10.
11.

Characterization of Epstein-Barr virus BGLF4 kinase expression control at the transcriptional and translational levels.

Wang JT, Chuang YC, Chen KL, Lu CC, Doong SL, Cheng HH, Chen YL, Liu TY, Chang Y, Han CH, Yeh SW, Chen MR.

J Gen Virol. 2010 Sep;91(Pt 9):2186-96. doi: 10.1099/vir.0.019729-0.

PMID:
20444992
12.

Epstein-Barr virus BGLF4 kinase downregulates NF-κB transactivation through phosphorylation of coactivator UXT.

Chang LS, Wang JT, Doong SL, Lee CP, Chang CW, Tsai CH, Yeh SW, Hsieh CY, Chen MR.

J Virol. 2012 Nov;86(22):12176-86. doi: 10.1128/JVI.01918-12.

13.

Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus.

Gershburg E, Raffa S, Torrisi MR, Pagano JS.

J Virol. 2007 May;81(10):5407-12.

14.
15.

Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles.

Wang JT, Yang PW, Lee CP, Han CH, Tsai CH, Chen MR.

J Gen Virol. 2005 Dec;86(Pt 12):3215-25.

PMID:
16298966
16.

Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.

Shen CL, Liu CD, You RI, Ching YH, Liang J, Ke L, Chen YL, Chen HC, Hsu HJ, Liou JW, Kieff E, Peng CW.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2229-34. doi: 10.1073/pnas.1525444113.

17.

Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication.

Iwahori S, Murata T, Kudoh A, Sato Y, Nakayama S, Isomura H, Kanda T, Tsurumi T.

J Biol Chem. 2009 Jul 10;284(28):18923-31. doi: 10.1074/jbc.M109.015123.

18.

Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.

Lee EK, Kim SY, Noh KW, Joo EH, Zhao B, Kieff E, Kang MS.

Antiviral Res. 2014 Apr;104:73-83. doi: 10.1016/j.antiviral.2014.01.018.

19.

Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase.

Yang PW, Chang SS, Tsai CH, Chao YH, Chen MR.

J Gen Virol. 2008 Apr;89(Pt 4):884-95. doi: 10.1099/vir.0.83546-0.

PMID:
18343828
Items per page

Supplemental Content

Support Center